This is a Validated Antibody Database (VAD) review about mouse Ube2a, based on 4 published articles (read how Labome selects the articles), using Ube2a antibody in all methods. It is aimed to help Labome visitors find the most suited Ube2a antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ube2a synonym: HHR6A; HR6A; Mhr6a; ubiquitin-conjugating enzyme E2 A; E2 ubiquitin-conjugating enzyme A; RAD6 homolog A; ubiquitin carrier protein A; ubiquitin-conjugating enzyme E2A (RAD6 homolog); ubiquitin-conjugating enzyme HR6A; ubiquitin-protein ligase A
Bethyl
rabbit polyclonal |
| Bethyl Ube2a antibody (Bethyl Laboratories, A300-281A) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi |
rabbit polyclonal |
| Bethyl Ube2a antibody (Bethyl Lab, A300-281A) was used in western blot on mouse samples (fig 2j). EMBO J (2015) ncbi |
Invitrogen
rabbit polyclonal |
| In order to identify a misregulated ciRS-7-miRNA-7-UBE2A circuit in cases of sporadic Alzheimer's disease, Invitrogen Ube2a antibody (Invitrogen, PA5-29940) was used in western blot on human samples (fig 1b). Genes (Basel) (2016) ncbi |
Proteintech Group
rabbit polyclonal |
| In order to identify E2s that regulate the activation, translocation, and enzymatic functions of Parkin during mitochondrial quality control, Proteintech Group Ube2a antibody (ProteinTech Group, 11080-1-AP) was used in western blot on human samples at 1:5000 (fig 7). J Cell Sci (2014) ncbi |
Articles Reviewed
- Zhao Y, Alexandrov P, Jaber V, Lukiw W. Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7). Genes (Basel). 2016;7: pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments